CSP #105 – Dear Auditor: Why is this a high risk finding? Can we talk?
Full Audio
View Show IndexSegments
1. Dear Auditor: Why Is This a High Risk Finding? Can We Talk? – Robert Findlay – CSP #105
CISOs often have a love/hate relationship with auditors, as it is the auditors that are placing judgement on the adequacy of company cybersecurity controls. Join this session from the perspective of an IT Audit leader and former CISO, as to how to view the auditors and strengthen the cybersecurity program amid adversity. This segment is sponsored by Wiz. Visit https://securityweekly.com/wiz to learn more about them!
Guest
Currently the Global Head of IT Audit at Irish dairy and protein leader Glanbia, Bob has over 30 years IT, audit and security experience. Having started in mainframe computer operations for a French Bank in the 1980’s Bob has managed most IT functions including programming, project management and data centre operations in addition to significant stints in IT audit and as Chief Information Security Officer.
Bob started working in IT audit in the Audit Commission and has since managed and set up IT audit functions in global businesses, such as British Airways, The Co-operative Group, ARYZTA, Paddy Power and now Glanbia as well as spells consulting for EY.
Host
Todd Fitzgerald has built information Fortune 500/large company security programs for 20 years. Todd serves as VP, Cybersecurity Strategy and Chairman of the Cybersecurity Collaborative Executive Committee, was named 2016–17 Chicago CISO of the Year, ranked Top 50 Information Security Executive, authored 4 books including #1 Best Selling and 2020 CANON Hall of Fame Winner CISO COMPASS: Navigating Cybersecurity Leadership Challenges with Insights from Pioneers (2019), ground-breaking CISO Leadership: Essential Principles for Success, as well as contributions to a dozen others. Todd held senior leadership positions at Northern Trust, Grant Thornton International, Ltd, ManpowerGroup, WellPoint (Anthem) Blue Cross Blue Shield/ National Government Services, Zeneca/Syngenta, IMS Health and American Airlines.